Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Pfizer files PARP inhibitor for breast cancer in US, EU
Pfizer files PARP inhibitor for breast cancer in US, EU
Regulators on both sides of the Atlantic have accepted for review Pfizer’s PARP inhibitor talazoparib as a treatment for women with a hereditary BRCA mutation.
Blood test for pregnant women can predict premature birth
Blood test for pregnant women can predict premature birth
A new blood test for pregnant women detects with 75-80 percent accuracy whether their pregnancies will end in premature birth.
A trembling cursor or struggling to scroll online could be early signs of Parkinson's or Alzheimer's, reveal scientists Microsoft and Duke University analysed online activity of 31 million Americans
A trembling cursor or struggling to scroll online could be early signs of Parkinson's or Alzheimer's, reveal scientists Microsoft and Duke University analysed online activity of 31 million Americans
A shaking mouse cursor, slow scrolling speed and repetitive online searches could allow computers to spot early signs of Parkinson's or Alzheimer's disease.
In Missouri, J&J faces biggest trial yet alleging talc caused cancer
In Missouri, J&J faces biggest trial yet alleging talc caused cancer
NEW YORK (Reuters) - A lawsuit by 22 ovarian cancer patients against Johnson & Johnson went to trial on Wednesday in Missouri state court, marking the largest case the company has faced ov...
FDA warns websites to stop illegal online opioid sales
FDA warns websites to stop illegal online opioid sales
"The public needs to know that no one is authorized to sell or distribute opioids via the Internet in the U.
Human trials set for experimental HIV vaccine
Human trials set for experimental HIV vaccine
WEDNESDAY, June 6, 2018 -- An experimental HIV vaccine protected animals from dozens of strains of HIV.
Artificial bone marrow could take the fight to diseases of the blood
Artificial bone marrow could take the fight to diseases of the blood
A newly developed artificial bone marrow tissue could prove key to understanding the formation of human.
Study: Diuretic as effective as antibiotics to treat women's acne
Study: Diuretic as effective as antibiotics to treat women's acne
June 4 (UPI) -- Spironolactone, a diuretic drug, might be an effective alternative to antibiotics for the treatment of women's acne, according to a new study.
Phase II clinical study of elenbecestat demonstraytes safety and tolerability in MCI and mild to moderate Alzheimer’s disease at 18 months
Phase II clinical study of elenbecestat demonstraytes safety and tolerability in MCI and mild to moderate Alzheimer’s disease at 18 months
Eisai Co.
Results of Phase III RELEVANCE Study Comparing REVLIMID plus Rituximab (R²) Versus Rituximab Plus Chemotherapy in Patients with Previously Untreated Follicular Lymphoma to be Presented at ASCO 2018
Results of Phase III RELEVANCE Study Comparing REVLIMID plus Rituximab (R²) Versus Rituximab Plus Chemotherapy in Patients with Previously Untreated Follicular Lymphoma to be Presented at ASCO 2018
SUMMIT, N.
Tricida Announces Positive Pivotal Phase 3 Clinical Trial Results for TRC101 in CKD Patients With Metabolic Acidosis
Tricida Announces Positive Pivotal Phase 3 Clinical Trial Results for TRC101 in CKD Patients With Metabolic Acidosis
SOUTH SAN FRANCISCO, Calif.
Updated Results of Ongoing Multicenter Phase I Study of bb2121 anti-BCMA CAR T Cell Therapy Continue to Demonstrate Deep and Durable Responses in Patients with Late-Stage Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting
Updated Results of Ongoing Multicenter Phase I Study of bb2121 anti-BCMA CAR T Cell Therapy Continue to Demonstrate Deep and Durable Responses in Patients with Late-Stage Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting
SUMMIT, N.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand